This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Conaris Research Institute, Ferring B.v.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Venkataramana Dingari: Innovator in Pharmaceutical Compositions
Introduction
Venkataramana Dingari is a notable inventor based in Franklin Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral compositions. With a total of 2 patents, his work focuses on innovative formulations that enhance therapeutic efficacy.
Latest Patents
Dingari's latest patents include "Oral pharmaceutical compositions of nicotinamide" and "Oral pharmaceutical compositions of mesalazine." The first patent describes pharmaceutical compositions for the oral administration of nicotinamide, either alone or in combination with mesalazine. It details methods for creating these compositions, which feature delayed-immediate and delayed-extended release formulations. The second patent focuses on mesalazine, outlining similar methods and formulations for its oral administration.
Career Highlights
Throughout his career, Venkataramana Dingari has worked with reputable organizations, including Conaris Research Institute AG and Ferring B.V. His experience in these companies has contributed to his expertise in pharmaceutical innovations.
Collaborations
Dingari has collaborated with various professionals in the field, including Alfred Chi Yeh Liang, enhancing the scope and impact of his work.
Conclusion
Venkataramana Dingari's contributions to pharmaceutical compositions demonstrate his commitment to innovation in healthcare. His patents reflect a deep understanding of drug formulation, which has the potential to improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile